Home » Stocks » BICX

BioCorRx Inc. (BICX)

Stock Price: $4.00 USD 0.01 (0.25%)
Updated Jul 29, 2021 3:37 PM EDT - Market closed
Market Cap 26.41M
Revenue (ttm) 95,850
Net Income (ttm) -3.99M
Shares Out 6.02M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $4.00
Previous Close $3.99
Change ($) 0.01
Change (%) 0.25%
Day's Open 3.59
Day's Range 3.59 - 4.59
Day's Volume 1,637
52-Week Range 0.57 - 5.66

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ANAHEIM, CA, June 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substanc...

1 month ago - GlobeNewsWire

ANAHEIM, CA, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --  BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substanc...

2 months ago - GlobeNewsWire

ANAHEIM, CA, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substan...

3 months ago - GlobeNewsWire

ANAHEIM, CA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorder...

3 months ago - GlobeNewsWire

ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorder...

4 months ago - GlobeNewsWire

ANAHEIM, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders...

6 months ago - GlobeNewsWire

About BICX

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The... [Read more...]

Industry
Medical Care Facilities
CEO
Brady Granier
Country
United States
Stock Exchange
OTCMKTS
Ticker Symbol
BICX
Full Company Profile

Financial Performance

In 2020, BioCorRx's revenue was $122,621, a decrease of -48.96% compared to the previous year's $240,259. Losses were -$3.47 million, -42.51% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for BioCorRx is 5.65, which is an increase of 41.25% from the latest price.

Price Target
$5.65
(41.25% upside)